“…32,33 In this light, an increasing number of studies have shown that TNS is beneficial for seizure control, depression, and migraine, and, very recently, the FDA approved a clinical trial for TNS treatment of Lennox-Gastaut syndrome. 34 In addition to epilepsy and depression, researchers have proposed a clinical application for VNS and TNS for treating variety of disorders, such as migraine, 35 anxiety, 36 cognitive impairment, 37,38 Alzheimer's disease, 39 autism, 40 tinnitus, 41,42 poststroke symptoms, [43][44][45] post-traumatic stress disorder, 46 eating disorders 47 and obesity. 48 Although clinical trials on the topic are accumulating, most of them are preliminary proof-ofconcept pilot studies obtained with limited sample sizes.…”